Skip to main content

Research Repository

Advanced Search

Impact of modified-release opioid use on clinical outcomes following total hip and knee arthroplasty: a propensity score-matched cohort study

Liu, S.; Patanwala, A. E.; Naylor, J. M.; Levy, N.; Knaggs, R.; Stevens, J. A.; Bugeja, B.; Begley, D.; Khor, K. E.; Lau, E.; Allen, R.; Adie, S.; Penm, J.

Impact of modified-release opioid use on clinical outcomes following total hip and knee arthroplasty: a propensity score-matched cohort study Thumbnail


Authors

S. Liu

A. E. Patanwala

J. M. Naylor

N. Levy

ROGER KNAGGS Roger.Knaggs@nottingham.ac.uk
Professor of Pain Management

J. A. Stevens

B. Bugeja

D. Begley

K. E. Khor

E. Lau

R. Allen

S. Adie

J. Penm



Abstract

Modified-release opioids are often prescribed for the management of moderate to severe acute pain following total hip and knee arthroplasty, despite recommendations against their use due to increasing concerns regarding harm. The primary objective of this multicentre study was to examine the impact of modified-release opioid use on the incidence of opioid-related adverse events compared with immediate-release opioid use, among adult inpatients following total hip or knee arthroplasty. Data for total hip and knee arthroplasty inpatients receiving an opioid analgesic for postoperative analgesia during hospitalisation were collected from electronic medical records of three tertiary metropolitan hospitals in Australia. The primary outcome was the incidence of opioid-related adverse events during hospital admission. Patients who received modified with or without immediate-release opioids were matched to those receiving immediate-release opioids only (1:1) using nearest neighbour propensity score matching with patient and clinical characteristics as covariates. This included total opioid dose received. In the matched cohorts, patients given modified-release opioids (n = 347) experienced a higher incidence of opioid-related adverse events overall, compared with those given immediate-release opioids only (20.5%, 71/347 vs. 12.7%, 44/347; difference in proportions 7.8% [95%CI 2.3–13.3%]). Modified-release opioid use was associated with an increased risk of harm when used for acute pain during hospitalisation after total hip or knee arthroplasty.

Citation

Liu, S., Patanwala, A. E., Naylor, J. M., Levy, N., Knaggs, R., Stevens, J. A., …Penm, J. (2023). Impact of modified-release opioid use on clinical outcomes following total hip and knee arthroplasty: a propensity score-matched cohort study. Anaesthesia, 78(10), 1237-1248. https://doi.org/10.1111/anae.16070

Journal Article Type Article
Acceptance Date May 19, 2023
Online Publication Date Jun 26, 2023
Publication Date 2023-10
Deposit Date Aug 16, 2023
Publicly Available Date Aug 18, 2023
Journal Anaesthesia
Print ISSN 0003-2409
Electronic ISSN 1365-2044
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 78
Issue 10
Pages 1237-1248
DOI https://doi.org/10.1111/anae.16070
Keywords Adverse events; modified-release; opioids; total hip arthroplasty; total knee arthroplasty
Public URL https://nottingham-repository.worktribe.com/output/21917019
Publisher URL https://associationofanaesthetists-publications.onlinelibrary.wiley.com/doi/10.1111/anae.16070
Additional Information Accepted: 2023-05-19; Published: 2023-06-26

Files





You might also like



Downloadable Citations